investordatabase.org

Foreground Capital

foreground.vc Direct investor

Foreground Capital is a venture capital firm launched in 2024 that invests in early-stage women's health companies across life sciences, devices, diagnostics, digital health, services and consumer health. It continues to manage the legacy RH Capital Fund I and II.

Foreground Capital is a venture capital firm, founded in 2024. It invests directly in companies, from seed to Series A, in women's health, biopharma, devices and diagnostics.

“We invest in companies addressing conditions that affect women directly, such as reproductive, maternal, and hormonal health; as well as conditions that disproportionately and differently impact women.”

— Foreground Capital, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series A
Sectors
women's health, biopharma, devices, diagnostics, digital health, tech-enabled services, consumer health
Founded
2024

Team, as Foreground Capital publishes it

  • Elizabeth Bailey Managing Partner
  • Stasia Obremskey Managing Partner
  • Yvanka de Soysa, PhD Senior Associate
  • Molly Ward Chief of Staff
  • Alice Zheng, MD Partner

Names and roles exactly as listed on foreground.vc. Nothing else about these people is recorded.

Named by events

Each event below names or links Foreground Capital on its own website — as the firm of a speaker, a partner or a listed investor. The event is the source, not the investor; it says nothing about who will be in the room.

Where this comes from

Every fact above was read from a page Foreground Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 21856 · added 2026-11-16 · link last verified 2026-11-16 · confidence high

Similar investors

Listed under